Substance / Medication

Magnesium stearate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution.
Calahan Julie L, Paul Shubhajit, Yanez Evelyn G et al. · Pharm Dev Technol · 2021
PMID: 33267700Observational
Evaluation of the lubricating effect of magnesium stearate and glyceryl behenate solid lipid nanoparticles in a direct compression process.
Martínez-Acevedo Lizbeth, Zambrano-Zaragoza María de la Luz, Vidal-Romero Gustavo et al. · Int J Pharm · 2018
PMID: 29729408Observational
A comparative study of glycerin fatty acid ester and magnesium stearate on the dissolution of acetaminophen tablets using the analysis of available surface area.
Uchimoto Takeaki, Iwao Yasunori, Takahashi Kana et al. · Eur J Pharm Biopharm · 2011
PMID: 21284955Observational
Magnesium stearate increases salbutamol sulphate dispersion: what is the mechanism?
Tay Tracy, Das Shyamal, Stewart Peter · Int J Pharm · 2010
PMID: 19748561Observational
Rapid quantitative analysis of magnesium stearate in tablets using laser-induced breakdown spectroscopy.
St-Onge Louis, Archambault Jean-Francois, Kwong Elizabeth et al. · J Pharm Pharm Sci · 2005
PMID: 16124938Observational
Structural properties of magnesium stearate pseudopolymorphs: effect of temperature.
Bracconi Pierre, Andrès Cyrille, Ndiaye Augustin · Int J Pharm · 2003
PMID: 12927393Observational
Effect of magnesium stearate on the content uniformity of active ingredient in pharmaceutical powder mixtures.
Swaminathan Vidya, Kildsig Dane O · AAPS PharmSciTech · 2002
PMID: 12916934ObservationalFull text (PMC)
Evaluation of the Mixing Characteristics of Magnesium Stearate Using Triboelectric Properties.
Fujinuma Kenta, Ito Masataka, Yonemochi Etsuo et al. · Chem Pharm Bull (Tokyo) · 2025
PMID: 39909454Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Magnesium stearate (substance)
SNOMED CT
40471006
UMLS CUI
C0126791

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.